Search by Drug Name or NDC
NDC 63323-0712-25 Kabiven 467; 330; 99; 29; 10.8; 164; 231; 199; 164; 231; 263; 96; 164; 231; 174; 199; 131; 239; 147; 3.9; 164; 55; 6.7; 213 mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL Details
Kabiven 467; 330; 99; 29; 10.8; 164; 231; 199; 164; 231; 263; 96; 164; 231; 174; 199; 131; 239; 147; 3.9; 164; 55; 6.7; 213 mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL
Kabiven is a INTRAVENOUS INJECTION, EMULSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ALANINE; ARGININE; ASPARTIC ACID; CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; METHIONINE; PHENYLALANINE; POTASSIUM CHLORIDE; PROLINE; SERINE; SODIUM .
Product Information
| NDC | 63323-0712 |
|---|---|
| Product ID | 63323-712_35adedd7-934f-4be9-8802-05c5993fce92 |
| Associated GPIs | 80451010001635 |
| GCN Sequence Number | 053071 |
| GCN Sequence Number Description | AA 3.31 %/D9.8W/fat/e-lytes 10 EMULSION 3.31%-9.8% INTRAVEN |
| HIC3 | C9C |
| HIC3 Description | PARENTERAL AMINO ACID SOLUTIONS AND COMBINATIONS |
| GCN | 20407 |
| HICL Sequence Number | 025607 |
| HICL Sequence Number Description | AMINO ACID 3.31 % NO.1/D9.8W/FAT EMULSIONS/ELECTROLYTE NO.10 |
| Brand/Generic | Brand |
| Proprietary Name | Kabiven |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dextrose, Soybean oil, Electrolytes, Lysine, Phenylalanine, Leucine, Valine, Threonine, Methionine, Isoleucine, Tryptophan, Alanine, Arginine, Glycine, Proline, Histidine, Glutamic Acid, Serine, Aspartic Acid and Tyrosine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, EMULSION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 467; 330; 99; 29; 10.8; 164; 231; 199; 164; 231; 263; 96; 164; 231; 174; 199; 131; 239; 147; 3.9; 164; 55; 6.7; 213 |
| Active Ingredient Units | mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
| Substance Name | ALANINE; ARGININE; ASPARTIC ACID; CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; METHIONINE; PHENYLALANINE; POTASSIUM CHLORIDE; PROLINE; SERINE; SODIUM |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Mot |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA200656 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0712-25 (63323071225)
| NDC Package Code | 63323-712-25 |
|---|---|
| Billing NDC | 63323071225 |
| Package | 2566 mL in 1 BAG (63323-712-25) |
| Marketing Start Date | 2014-08-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |